Colliers Securities Initiates Nutex Health(NUTX.US) With Buy Rating, Announces Target Price $56
Maxim Group Maintains Nutex Health(NUTX.US) With Buy Rating, Raises Target Price to $50
Nutex Health Analyst Ratings
Benchmark Co. Maintains Nutex Health(NUTX.US) With Buy Rating, Raises Target Price to $60
Maxim Group Initiates Nutex Health(NUTX.US) With Buy Rating, Announces Target Price $45
Nutex Health Analyst Ratings
Benchmark Co. Maintains Nutex Health(NUTX.US) With Buy Rating, Cuts Target Price to $45
Nutex Health Analyst Ratings
Benchmark Maintains Buy on Nutex Health, Lowers Price Target to $1.5
Nutex Health Analyst Ratings
Benchmark Reiterates Buy on Nutex Health, Maintains $2.5 Price Target
Nutex Health Analyst Ratings
Benchmark Adjusts Price Target on Nutex Health to $2.50 From $3, Maintains Buy Rating
Benchmark Maintains Buy on Nutex Health, Lowers Price Target to $2.5
Nutex Health Analyst Ratings
Benchmark Initiates Coverage On Nutex Health With Buy Rating, Announces Price Target of $3